Latest Breaking News On - பல்கலைக்கழகம் மருத்துவமனை க்ரீஃப்ஸ்‌வால்ட் - Page 6 : comparemela.com

A research group in Germany has presented a possible explanation for why the Johnson & Johnson COVID-19 vaccines sometimes trigger rare blood-clotting events. But not all experts are convinced the explanation is correct. The group, led by Dr. Andreas Greinacher, head of the Institute of Immunology and Transfusion Medicine at University Hospital Greifswald, suggests a chain reaction that involves a preservative and certain proteins in the vaccines may be responsible for the rare blood clots.  The team has completed relevant studies only on the AstraZeneca vaccine and recently began examining the Johnson & Johnson vaccine, The Wall Street Journal reported. However, Greinacher said he suspects that the mechanism that causes the rare

Mecklenburg vorpommernJohn keltonAndreas greinacherCansino biologicsInstitute of immunologyResearch squareMcmaster university in ontarioErasmus universityRussian ministry of health gamaleya research instituteTransfusion medicine at university hospital greifswaldTransfusion medicineUniversity hospital greifswaldWall street journalRussian ministryGamaleya research instituteMcmaster university